Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

units in services that do not currently have them, and this will reduce hospital stays in those services. Return to recommendations Anticoagulation treatment for suspected or confirmed deep vein thrombosis or pulmonary embolism Recommendations 1.3.1 to 1.3.21 Why the committee made the recommendations Interim therapeutic anticoagulation for suspected DVT or PE There was no evidence specifically on interim anticoagulation treatment for suspected DVT or PE. However, the committee agreed that it is vital to start treatment if DVT or PE is suspected and diagnostic test results are delayed by more than 4 hours. They reasoned that anticoagulation treatments that are effective for confirmed DVT or PE are likely to be equally effective when used as interim treatment while awaiting a confirmed diagnosis. They also noted that continuing the same anticoagulant treatment after diagnosis offers benefits in terms of safety and convenience. However, they acknowledged that local protocols or availability of anticoagulants for suspected VTE may necessitate the use of different anticoagulants before and after diagnosis. The committee agreed that when choosing an interim anticoagulant, clinicians should always take individual clinical circumstances into account, including whether the person is at an extreme of body weight, has PE with haemodynamic instability, renal
